UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50
UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.
Stocks · News reference
Helmerich & Payne Q3 2026 Earnings Call Transcript
On Thursday, Helmerich & Payne (NYSE:HP) discussed third-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51
Barclays analyst Eddie Kim maintains Helmerich & Payne (NYSE:HP) with a Overweight and raises the price target from $50 to $51.
8-K filing — Helmerich & Payne, Inc. (HP)
Filed: 2026-10-07 AccNo: 0000046765-26-000055 Size: 532 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits